Federal contract receipt
$2,773,098 from Department of Health and Human Services to PPD DEVELOPMENT LP
FIRST IN HUMAN RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED SINGLE ASCENDING DOSE (SAD) PHASE I STUDY
Signals
Full and openSeven-figure awardMulti-year performance
Office of Federal Procurement Policy
Public Spend Intelligence - sledai.com
Award #CONT_AWD_75N95024F00001_7529_HHSN271201600005I_7529
Signed2024-09-12
VendorPPD DEVELOPMENT LP
PlaceNC
FIRST IN HUMAN RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED SINGLE ASCENDING DOSE (SAD) PHASE I STUDY
Total obligated$2,773,098.00
PoP Start
2016-07-08
PoP End
2026-06-30
COMPETED
Awarded on 2024-09-12
Vendor
PPD DEVELOPMENT LP
Agency
Department of Health and Human Services
Category
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
Place
NC
© 2025 Sled AI Inc. All rights reserved.